NDC 60505-0141-01 - Glipizide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-0141
- Requested NDC
- 60505-0141-01
- Package NDCs from labels
- 60505-0141-0, 60505-0141-2, 60505-0141-1, 60505-0141-8, 60505-0141-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glipizide - A-S Medication Solutions | A-S Medication Solutions | 2026-10-13 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | REMEDYREPACK INC. | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | NuCare Pharmaceuticals,Inc. | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | Apotex Corp. | Apotex Inc. | 2026-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - American Health Packaging | American Health Packaging | 2026-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | Coupler LLC | Apotex Inc. | 2026-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | Preferred Pharmaceuticals, Inc. | 2026-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - Major Pharmaceuticals | Major Pharmaceuticals | 2026-03-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - Legacy Pharmaceutical Packaging, LLC | Legacy Pharmaceutical Packaging, LLC | 2026-03-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - A-S Medication Solutions | A-S Medication Solutions | 2026-02-20 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg Rx Only | PD-Rx Pharmaceuticals, Inc. | 2026-02-16 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | REMEDYREPACK INC. | 2026-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - AvPAK | AvPAK | 2026-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - QPharma Inc | APOTEX CORP. | Northwind Health Company, LLC | QPharma Inc | APOTEX CORP. | Northwind Health Company, LLC | 2025-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | NuCare Pharmaceuticals,Inc. | 2025-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-0141-0 | Glipizide | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 60505-0141-1 | Glipizide | 1000 in 1 BOTTLE | TABLET | 1000 | 13 | |
| 60505-0141-2 | Glipizide | 500 in 1 BOTTLE | TABLET | 500 | 13 | |
| 60505-0141-8 | Glipizide | 18000 in 1 BOTTLE | TABLET | 18000 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-0141 | GLIPIZIDE TABLET [APOTEX CORP.] | 12 | Current NDC, Legacy NDC, 4 package rows | 20240927_dcf426b8-bcdc-8214-a1b6-6388bd3399a0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0141-0 | EA - Each | 60505-0141 | 060fe002-7e4b-48fa-b8ff-db2d3828c7f4 | 1 | 2012-07-24 |
| 60505-0141-1 | EA - Each | 60505-0141 | e7c50d52-216d-49a4-af7f-5c321f139ee5 | 1 | 2012-07-24 |
| 60505-0141-2 | EA - Each | 60505-0141 | f4681913-5f1e-4f36-a5c9-bb72a51d1b76 | 1 | 2012-07-24 |
| 60505-0141-8 | EA - Each | 60505-0141 | 1dbe3016-8158-4460-bb2b-dd466eed8d63 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cell Salt Combination 8013 | CELL SALT COMBINATION | Professional Complementary Health Formulas | b3a33345-3c3d-4f86-ae4d-757c65fd1ed3 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| RET Heart 7009 | RET HEART | Professional Complementary Health Formulas | e2bf8331-1c50-4216-93a4-1d3cf6404759 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Lumbar Drops 5013 | LUMBAR DROPS | Professional Complementary Health Formulas | ee6b54ea-fb6a-4723-8a0f-970aa82fea80 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Rehydration Drops 2175 | REHYDRATION DROPS | Professional Complementary Health Formulas | 58cc2bd1-c530-43bf-876e-f30d4d95b8da | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Dysfunctional Bleeding Drops 2138 | DYSFUNCTIONAL BLEEDING DROPS | Professional Complementary Health Formulas | 3e674c1e-c64b-416d-962f-c03493e80085 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Cervical Drops 5002 | CERVICAL DROPS | Professional Complementary Health Formulas | edd5f196-1423-4d4c-a8c1-89427c4f387e | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Asbestox 6005 | ASBESTOX | Professional Complementary Health Formulas | 90bc0d00-01e4-4134-809e-e216fd09852a | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Ledum Combination 9257 | LEDUM COMBINATION | Professional Complementary Health Formulas | 38b89b32-4915-487d-8b2d-250123487b15 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Fourth Chakra (Heart) 7304 | FOURTH CHAKRA (HEART) | Professional Complementary Health Formulas | ef061447-42ae-43d0-b6f3-bf19a96ffe92 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Spinal Drops 5025 | SPINAL DROPS | Professional Complementary Health Formulas | ca6d7250-9c9e-40a6-8d41-88aba33d21dd | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Anti-Scar Drops 2084 | ANTI-SCAR DROPS | Professional Complementary Health Formulas | ad0e9159-ed68-48aa-a7d1-7ff5c32ec304 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Fifth Chakra (Throat) 7305 | FIFTH CHAKRA (THROAT) | Professional Complementary Health Formulas | b731f708-10a8-451f-8550-1e7302102b96 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Sixth Chakra (Third Eye) 7306 | SIXTH CHAKRA (THIRD EYE) | Professional Complementary Health Formulas | 174024e7-e231-456c-bc00-48a358d7160a | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Injury Drops 2034 | INJURY DROPS | Professional Complementary Health Formulas | 024011a0-6471-4016-86d4-19eeb21f0d82 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Third Chakra (Solar Plexus) 7303 | THIRD CHAKRA (SOLAR PLEXUS) | Professional Complementary Health Formulas | eea89c37-ab87-4cc7-8dfc-e7f42a580dd9 | 2026-01-08 | Warnings | ETJ7Z6XBU4 |
| Lymphastat | BAPTISIA TINCTORIA, ECHINACEA (ANGUSTIFOLIA), LOBELIA INFLATA, LOMATIUM DISSECTUM, HYDRASTIS CANADENSIS, LUNG (SUIS), PHYTOLACCA DECANDRA, SYMPHYTUM OFFICINALE, ACONITUM NAPELLUS, ARSENICUM ALBUM, BELLADONNA, BRYONIA (ALBA), CAUSTICUM, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS, HYPERICUM PERFORATUM, KALI CARBONICUM, LACHESIS MUTUS, NATRUM SULPHURICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), RHUS TOX, SILICEA, SULPHUR, PYROGENIUM | Energique, Inc. | ff95b833-3760-4e34-9636-90b423fc0d7b | 2026-01-07 | Warnings | ETJ7Z6XBU4 |
| Glipizide | GLIPIZIDE | Northstar Rx LLC. | 915636a4-092e-4e2e-9bc0-0d387d996977 | 2026-01-05 | Warnings, Adverse reactions | X7WDT95N5C |
| Parathyropar | SYMPHYTUM OFFICINALE, BARYTA CARBONICA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, HEKLA LAVA, MANGANUM METALLICUM, PARATHYROID GLAND (BOVINE), RHUS TOX, SILICEA | Energique, Inc. | 6b098910-2f36-4757-a463-e01105340c43 | 2026-01-05 | Warnings | ETJ7Z6XBU4 |
| VACC HC | ANTIMONIUM TARTARICUM, ARSENICUM ALBUM, BRYONIA (ALBA), ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYOSCYAMUS NIGER, INFLUENZINUM, LEDUM PALUSTRE, MERCURIUS SOLUBILIS, MEZEREUM, NICOTINAMIDUM, HUMAN CORONAVIRUS (RNA), SENEGA OFFICINALIS, SILICEA, SPIGELIA ANTHELMIA, SULPHUR, THUJA OCCIDENTALIS, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 16d782b2-1bef-45e5-8a1d-721b1ffe5631 | 2026-01-05 | Warnings | ETJ7Z6XBU4 |
| Glipizide | GLIPIZIDE | Northwind Health Company, LLC | c16edad6-4271-6ff0-e053-2a95a90a0240 | 2026-01-01 | Warnings, Adverse reactions | ANDA075795 51655-180-25 51655-180-52 51655-180-26 51655-180 310490 48c42223-ff56-f7b4-e063-6294a90a9284 c16edad6-4271-6ff0-e053-2a95a90a0240 X7WDT95N5C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.